Catalyst Wire Dossier Catalyst Wire Dossier

Ateronon

· Omicron Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ateronon, covering 2013-05-21 to 2013-05-21. Get the full timeline:

Most recent: Clinical Trial Update: Trial of Ateronon in Patients With Coronary Disease to Evaluate Its Effectiveness in Assessing the Risk Factors of Atherosclerosis [Phase 3]

See pricing